White Papers
-
Insights: Global Patient Views And Engagement In Clinical Trials
4/15/2024
Enhancing the patient journey within clinical trials begins with engaging participants to understand their needs and preferences, ensuring they enroll and remain committed throughout the study.
-
Patient Diversity: Identifying Challenges, Opportunities, And Best Practices
4/10/2024
By listening to the voice of patient diversity and implementing FDA guidance measures, learn how stakeholders can improve trust, engagement, data reliability, patient outcomes, and promote public health.
-
Cystic Fibrosis: Global Clinical Trial Landscape (2024)
4/8/2024
Gain valuable insights on patient enrollment, site selection, and navigating global regulatory landscapes tailored to rare diseases, thus propelling forward CF research and treatment.
-
Acute Myeloid Leukaemia: Global Clinical Trial Landscape (2024)
4/8/2024
Learn how the collaboration among researchers, healthcare providers, and pharmaceutical industries holds promise for progress in Acute Myeloid Leukaemia management and care.
-
Digital Biomarker Upholds Adherence, User Satisfaction, Validity
3/25/2024
Clinical outcome assessments can present challenges in clinical trials. Discover how this solution is able to utilize digital biomarkers to identify and measure clinically relevant signals in neurological conditions.
-
Digital Endpoint Resource Guide: Rheumatology
3/19/2024
Explore how wearables and sensor-based technologies provide continuous, remote patient-centered outcomes, reducing trial participation burdens, increasing success probabilities, and enhancing condition management.
-
Achieving Statistical Significance With Limited Patient Populations
3/15/2024
Explore highlights from a timely panel debate on emerging approaches to clinical research and data collection for advanced, novel and personalized therapies, especially linked to rare diseases.
-
Digital Endpoint Resource Guide: Neuromuscular Disorders
3/15/2024
Find out how sensor-based digital health technologies (DHTs) offer direct, objective daily life assessments, accelerating NMD drug development.
-
Bringing In Vitro Diagnostics To Market With Real-World Evidence
3/14/2024
Explore the potential of real-world evidence in enhancing the regulatory decision-making process to facilitate the market entry of IVDs.
-
Study Start-Up Challenges: Hard Realities, Effective Strategies
3/13/2024
Launching a study is complex, and the time between protocol approval and the first patient visit has increased dramatically. How can companies reverse this trend and accelerate study start-ups?